BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1903192)

  • 1. Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices.
    Sivin I
    Obstet Gynecol; 1991 Jun; 77(6):960-1. PubMed ID: 1903192
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices.
    Toivonen J; Luukkainen T; Allonen H
    Obstet Gynecol; 1991 Feb; 77(2):261-4. PubMed ID: 1899136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of uterine artery blood flow with levonorgestrel intrauterine system and copper intrauterine device.
    Haliloglu B; Celik A; Ilter E; Bozkurt S; Ozekici U
    Contraception; 2011 Jun; 83(6):578-81. PubMed ID: 21570557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
    Lehtovirta P; Paavonen J; Heikinheimo O
    Contraception; 2007 Jan; 75(1):37-9. PubMed ID: 17161122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility regulation technology: status and prospects.
    Segal SJ; Nordberg OS
    Popul Bull; 1977 Mar; 31(6):1-25. PubMed ID: 12335682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine devices.
    Bilian X
    Best Pract Res Clin Obstet Gynaecol; 2002 Apr; 16(2):155-68. PubMed ID: 12041959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconsidering IUDs.
    Goldberg B
    AVSC News; 1992 Jul; 30(2):7-8. PubMed ID: 12285571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term experience of a levonorgestrel-releasing intrauterine system.
    Odlind V
    Eur J Contracept Reprod Health Care; 1996 Dec; 1(4):319-23. PubMed ID: 9678114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices.
    Dallenbach-Hellweg G
    Int J Gynecol Pathol; 1988; 7(1):95-6. PubMed ID: 3127347
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative study.
    Ng YW; Liang S; Singh K
    Contraception; 2009 Jan; 79(1):24-8. PubMed ID: 19041437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
    Rönnerdag M; Odlind V
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):716-21. PubMed ID: 10468065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the effect of various dosages of anordrin and levonorgestrel on the pituitary responsiveness to GnRH].
    Lu WY; Hsieh CM; Xu MH; Nan ZY
    Sheng Li Xue Bao; 1988 Jun; 40(3):271-7. PubMed ID: 3142042
    [No Abstract]   [Full Text] [Related]  

  • 17. Intrauterine devices.
    Mccarthy TG; Ratnam SS
    Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC).
    van Vliet HA; Tchaikovski SN; Rosendaal FR; Rosing J; Helmerhorst FM
    Thromb Haemost; 2009 Apr; 101(4):691-5. PubMed ID: 19350113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post coital contraception.
    Haspels AA; Van Santen MR
    J Gynaecol Endocrinol; 1986; 2(1-2):17-24. PubMed ID: 12269214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The levonorgestrel-releasing intrauterine device.
    Toivonen J
    Adv Contracept Deliv Syst; 1994; 10(3-4):191-8. PubMed ID: 12287838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.